Results 1 to 10 of about 43,194 (232)

Duration of untreated bipolar disorder: A multicenter study [PDF]

open access: yes, 2017
Little is known about the demographic and clinical differences between short and long duration of untreated bipolar disorder (DUB) in Chinese patients.
Chiu, Helen F.K.   +11 more
core   +2 more sources

Effects of lamotrigine on attention-deficit hyperactivity disorder in pediatric epilepsy patients [PDF]

open access: yesKorean Journal of Pediatrics, 2017
PurposeThe purpose of this study was to investigate the effects of lamotrigine for the treatment of attention-deficit hyperactivity disorder (ADHD) symptoms in children with epilepsy.MethodsPediatric patients newly diagnosed with epilepsy (n=90 [61 boys ...
Seung-A Han   +3 more
doaj   +1 more source

Data on the relationship between lamotrigine and levetiracetam serum/plasma levels and toxicity: Experience at an academic medical center

open access: yesData in Brief, 2021
Lamotrigine and levetiracetam are second-generation anti-epileptic drugs used for the management of seizure disorders and some other medical conditions. In the related research article using retrospective data from an academic medical center, we analyzed
Kelly E. Wood   +2 more
doaj   +1 more source

Prospective, open-label trial measuring satisfaction and convenience of two formulations of lamotrigine in subjects with mood disorders

open access: yesPatient Preference and Adherence, 2013
Martha Sajatovic,1 Thomas R Thompson,2 Kevin Nanry,3 Suzanne Edwards,2 Ranjani Manjunath21Case Western Reserve University School of Medicine and University Hospitals of Cleveland, Cleveland, OH, 2GlaxoSmithKline, Research Triangle Park, NC; 3Quintiles ...
Sajatovic M   +4 more
doaj  

Severe Cutaneous Adverse Reactions Associated With High-Dose Lamotrigine for Mood Disorders: A Case Series

open access: yesINNOVATIONS in Pharmacy, 2022
Drug-induced Eosinophilia and Systemic Symptoms (DRESS), Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN) are rare but life-threatening immune-mediated drug reactions known as Severe Cutaneous Adverse Reactions (SCARs).
Abigale Clark, Blake St. Clair
doaj  

Supplementary Figure S4 from FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth [PDF]

open access: gold, 2023
Michele Pellegrino   +10 more
openalex   +1 more source

Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model

open access: yesEpilepsia Open, 2019
Objective The lamotrigine‐resistant amygdala kindling model uses repeated administration of a low dose of lamotrigine during the kindling process to produce resistance to lamotrigine, which also extends to some other antiseizure drugs (ASDs).
Cameron S. Metcalf   +5 more
doaj   +1 more source

Hypotonia and poor feeding in an infant exposed to lamotrigine and valproic acid in utero

open access: yesThe Turkish Journal of Pediatrics, 2013
Lamotrigine has been considered a safe new-generation antiepileptic drug during the perinatal period for both mothers and infants. Despite the concerns regarding its possible teratogenic effect, very limited data have been reported on the adverse ...
Sahin Takcı   +3 more
doaj   +1 more source

Toxic epidermal necrolysis induced by lamotrigine treatment in a child [PDF]

open access: yesKorean Journal of Pediatrics, 2014
Toxic epidermal necrolysis is an unpredictable and severe adverse drug reaction. In toxic epidermal necrolysis, epidermal damage appears to result from keratinocyte apoptosis.
Youngsuk Yi, Jeong Ho Lee, Eun Sook Suh
doaj   +1 more source

The use of intralipid emulsion therapy to treat severe cardiotoxicity secondary to lamotrigine ingestion in a dog

open access: yesClinical Case Reports, 2018
Key Clinical Message Lamotrigine is a sodium and calcium channel blocker, used to treat seizures in people. Dogs metabolize Lamotrigine to a cardiotoxic metabolite that causes severe, often fatal ventricular arrhythmias.
Tara J. Bellis, Laura Gibeon
doaj   +1 more source

Home - About - Disclaimer - Privacy